Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre
暂无分享,去创建一个
A. Gasbarrini | L. Lopetuso | L. Laterza | F. Scaldaferri | L. Guidi | A. Armuzzi | D. Pugliese | A. Papa | G. Privitera | G. Rapaccini | S. Onali | M. Pizzoferrato | C. Settanni | G. Rizzatti | V. Mora | E. Schiavoni | D. Napolitano | L. Turchini | V. Amatucci | T. Bernabei